These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1670 related articles for article (PubMed ID: 32011647)

  • 21. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review.
    Rashki Kemmak A; Abutorabi A; Alipour V
    Clin Drug Investig; 2020 Aug; 40(8):715-725. PubMed ID: 32578155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness and safety of direct oral anticoagulants compared to conventional pharmacologic thromboprophylaxis in hip fracture patients: A systematic review and meta-analysis of randomized controlled trials.
    Abatzis-Papadopoulos M; Tigkiropoulos K; Nikas S; Papoutsis I; Kostopoulou O; Stavridis K; Karamanos D; Lazaridis I; Saratzis N
    Orthop Traumatol Surg Res; 2023 Apr; 109(2):103364. PubMed ID: 35817368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
    Hajibandeh S; Hajibandeh S; Antoniou GA; Scurr JR; Torella F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011764. PubMed ID: 29161465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review.
    Brockbank J; Wolowacz S
    Pharmacoeconomics; 2017 May; 35(5):517-535. PubMed ID: 28185212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].
    Gómez-Cerezo JF; Gómez-Arrayás I; Suárez-Fernández C; Betegón-Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Cir Ortop Traumatol; 2012; 56(6):459-70. PubMed ID: 23594943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    An VV; Phan K; Levy YD; Bruce WJ
    J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomic evaluation of dabigatran, rivaroxaban and apixaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement in Spain.
    Gómez-Outes A; Avendaño-Solá C; Terleira-Fernández AI; Vargas-Castrillón E
    Pharmacoeconomics; 2014 Sep; 32(9):919-36. PubMed ID: 24895235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: A protocol for meta-analysis.
    Le G; Yang C; Zhang M; Xi L; Luo H; Tang J; Zhao J
    Medicine (Baltimore); 2020 Dec; 99(49):e23055. PubMed ID: 33285683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
    Nieto JA; Espada NG; Merino RG; González TC
    Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of aspirin in preventing venous thrombosis in major orthopedic surgery: An updated meta-analysis of randomized controlled trials.
    Liu HZ; Liang J; Hu AX
    Medicine (Baltimore); 2023 Oct; 102(42):e35602. PubMed ID: 37861503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
    Herlihy DR; Thomas M; Tran QH; Puttaswamy V
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening.
    Harrison-Brown M; Scholes C; Douglas SL; Farah SB; Kerr D; Kohan L
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020926790. PubMed ID: 32484038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.
    Santana DC; Emara AK; Orr MN; Klika AK; Higuera CA; Krebs VE; Molloy RM; Piuzzi NS
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32824931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M; Sobieraj DM
    Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.